Thanks Seven-up, I have to believe the Musculoskeletal Clearance played a part in Dr. Fischell's visit. Also, as you mention, hard to believe that the 426 million share trading day on the 28th was not related to Fischell's visit.
It is interesting that Dr. Fischell's Pain Relief Device, Zygood, does not seem to be going anywhere. The Zygood company was established in 2014. A 2019 SEC Form-D filing shows Zygood looking for $250k in Convertible Promissory Note Loans and "No Revenue" in the 'Issuer Size' category.